Advertisement

Topics

Entasis Therapeutics to Present Data at 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

08:00 EDT 21 Apr 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Entasis Therapeutics, a leader in the discovery and development of breakthrough anti-infective products, today announced two oral presentations at the 27th European Congress of Clinical Microbiology and Infectious Disease...

Other Sources for this Article

Company Contact
Entasis Therapeutics
Kyle Dow, 781-810-0114
kyle.dow@entasistx.com
or
Media Contact
MacDougall Biomedical Communications
Kari Watson, 781-235-3060
kwatson@macbiocom.com

NEXT ARTICLE

More From BioPortfolio on "Entasis Therapeutics to Present Data at 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)"

Quick Search
Advertisement
 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...